Live Breaking News & Updates on Prnewswire leap therapeutics inc

Stay informed with the latest breaking news from Prnewswire leap therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Prnewswire leap therapeutics inc and stay connected to the pulse of your community

Leap Therapeutics Announces $40 Million Private Placement

Leap Therapeutics Announces $40 Million Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , United-states , Matthew-deyoung , Douglase-onsi , Drug-administration , Prnewswire-leap-therapeutics-inc , Leap-therapeutics-inc , Exchange-commission , Nasdaq , Gilead-sciences-inc

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , San-francisco , California , American , Matthew-deyoung , Meredith-pelster , Douglase-onsi , Zev-wainberg , Drug-administration

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...

San-francisco , California , United-states , Cambridge , Cambridgeshire , United-kingdom , American , Zev-wainberg , Douglase-onsi , Matthew-deyoung , Meredith-pelster , Drug-administration

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tennessee , United-states , Cambridge , Cambridgeshire , United-kingdom , San-francisco , California , American , Douglase-onsi , Matthew-deyoung , Meredith-pelster , Msc-sarah-cannon-research-institute

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 21, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E....

New-york , United-states , Cambridge , Cambridgeshire , United-kingdom , Piper-sandler , Douglase-onsi , Prnewswire-leap-therapeutics-inc , Leap-therapeutics-inc , Nasdaq , Chief-executive-officer , Annual-healthcare-conference

Leap Therapeutics to Participate at Upcoming Investor Conferences

Leap Therapeutics to Participate at Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Douglase-onsi , Matthew-deyoung , Leap-therapeutics-inc , Prnewswire-leap-therapeutics-inc , Nasdaq , Chief-executive-officer , Presentation-details , Annual-global-investment , Leap-therapeutics

Leap Therapeutics Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United-states , Cambridge , Cambridgeshire , United-kingdom , Australia , China , Australian , American , Douglase-onsi , Matthew-deyoung , Novarock-biotherapeutics , Leap-therapeutics-inc

Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients

CAMBRIDGE, Mass., July 12, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that, based on the...

Cambridge , Cambridgeshire , United-kingdom , China , Douglase-onsi , Zev-wainberg , Matthew-deyoung , Novarock-biotherapeutics , Cynthia-sirard , Ucla-gi-oncology-program , Leap-therapeutics-inc , Prnewswire-leap-therapeutics-inc

Leap Therapeutics Announces Reverse Stock Split

CAMBRIDGE, Mass., June 20, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will effect... | June 20, 2023

Cambridge , Cambridgeshire , United-kingdom , China , Douglase-onsi , Matthew-deyoung , Novarock-biotherapeutics , Leap-therapeutics-inc , Nasdaq , Drug-administration , Continental-stock-transfer-trust-company , Prnewswire-leap-therapeutics-inc

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

United-states , Cambridge , Cambridgeshire , United-kingdom , Chicago , Illinois , Germany , South-korea , Republic-of-korea , American , Matthew-deyoung , Samuelj-klempner